Ketosis Suppression and Ageing (KetoSAge): The Effects of Suppressing Ketosis in Long Term Keto-Adapted Non-Athletic Females
暂无分享,去创建一个
T. Seyfried | B. Elliott | Isabella D Cooper | Y. Kyriakidou | A. Soto-Mota | Kurtis Edwards | Lucy Petagine | Tomas Duraj | Andrew Scarborough | Sandra L. Jacome | Kenneth Brookler | Valentina Borgognoni | Vanusa Novaes | Rima Al-Faour | Isabella D. Cooper
[1] B. Elliott,et al. Bio-Hacking Better Health—Leveraging Metabolic Biochemistry to Maximise Healthspan , 2023, Antioxidants.
[2] R. Halwani,et al. Assessing the Link between Diabetic Metabolic Dysregulation and Breast Cancer Progression , 2023, International journal of molecular sciences.
[3] A. Bianco,et al. The Effects of Ketogenic Diet on Insulin Sensitivity and Weight Loss, Which Came First: The Chicken or the Egg? , 2023, Nutrients.
[4] S. O'toole,et al. MCP‐1 expression in breast cancer and its association with distant relapse , 2023, Cancer medicine.
[5] Kyong Park,et al. Carbohydrate-based diet may increase the risk of cardiovascular disease: A pooled analysis of two prospective cohort studies. , 2023, Clinical nutrition.
[6] M. S. Ryu,et al. Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma. , 2023, Allergology international : official journal of the Japanese Society of Allergology.
[7] Gang Liu,et al. Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer’s Disease , 2023, Aging and disease.
[8] A. O’Halloran,et al. Sustaining an ageing population: The role of micronutrients in frailty and cognitive impairment. , 2023, The Proceedings of the Nutrition Society.
[9] Jiwon Kwak,et al. Serum γ-glutamyltransferase level and incidence risk of metabolic syndrome in community dwelling adults: longitudinal findings over 12 years , 2023, Diabetology & Metabolic Syndrome.
[10] C. Ingallina,et al. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food , 2023, Nutrients.
[11] Arwa R. Althaher. An Overview of Hormone-Sensitive Lipase (HSL) , 2022, TheScientificWorldJournal.
[12] V. Steenkamp,et al. The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy , 2022, International journal of molecular sciences.
[13] R. Rizzo,et al. The Evolution of Ketosis: Potential Impact on Clinical Conditions , 2022, Nutrients.
[14] Zhenfu Wang,et al. Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases , 2022, Aging and disease.
[15] R. Jha,et al. A Ketogenic Diet is Effective in Improving Insulin Sensitivity in Individuals with Type 2 Diabetes. , 2022, Current diabetes reviews.
[16] Yihai Cao,et al. The impact of VEGF on cancer metastasis and systemic disease. , 2022, Seminars in cancer biology.
[17] C. Ebbeling,et al. Prolonged Glycemic Adaptation Following Transition From a Low- to High-Carbohydrate Diet: A Randomized Controlled Feeding Trial , 2022, Diabetes care.
[18] E. Giovannucci,et al. Association between IGF‐1 levels ranges and all‐cause mortality: A meta‐analysis , 2022, Aging cell.
[19] H. Qin,et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations , 2022, Signal Transduction and Targeted Therapy.
[20] Linghua Mei,et al. Characteristics of peripheral blood Gamma-glutamyl transferase in different liver diseases , 2022, Medicine.
[21] Ling Liu,et al. Fasting Induces a Highly Resilient Deep Quiescent State in Muscle Stem Cells via Ketone Body Signaling , 2022, bioRxiv.
[22] Jinxin Lan,et al. MCP-1 targeting: Shutting off an engine for tumor development , 2021, Oncology letters.
[23] Z. Shakoor,et al. Expression of VEGF, EGF and HGF in early- and late-stage colorectal cancer. , 2021, Molecular and clinical oncology.
[24] Peijie Chen,et al. β-hydroxybutyrate as an Anti-Aging Metabolite , 2021, Nutrients.
[25] I. Kraev,et al. Preliminary Investigations Into the Effect of Exercise-Induced Muscle Damage on Systemic Extracellular Vesicle Release in Trained Younger and Older Men , 2021, Frontiers in Physiology.
[26] K. Brookler,et al. Rethinking Fragility Fractures in Type 2 Diabetes: The Link between Hyperinsulinaemia and Osteofragilitas , 2021, Biomedicines.
[27] C. V. van Karnebeek,et al. The ketogenic diet as a therapeutic intervention strategy in mitochondrial disease. , 2021, The international journal of biochemistry & cell biology.
[28] V. Viswanathan,et al. Hyperglucagonemia and impaired insulin sensitivity are associated with development of prediabetes and type 2 diabetes - A study from South India. , 2021, Diabetes & metabolic syndrome.
[29] B. Elliott,et al. Metabolic Phenotypes and Step by Step Evolution of Type 2 Diabetes: A New Paradigm , 2021, Biomedicines.
[30] I. Shelef,et al. Effect of Dietary Strategies on Respiratory Quotient and Its Association with Clinical Parameters and Organ Fat Loss: A Randomized Controlled Trial , 2021, Nutrients.
[31] V. Ravichandiran,et al. MCP-1: Function, regulation, and involvement in disease , 2021, International Immunopharmacology.
[32] R. Ajjan,et al. PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target , 2021, International journal of molecular sciences.
[33] P. Declerck,et al. A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? , 2021, International journal of molecular sciences.
[34] M. Nakao,et al. Murine neonatal ketogenesis preserves mitochondrial energetics by preventing protein hyperacetylation , 2021, Nature Metabolism.
[35] A. Holland-Winkler,et al. Reliability and diagnostic performance of a new blood ketone and glucose meter in humans , 2021, Journal of the International Society of Sports Nutrition.
[36] T. Hoppe,et al. Build-UPS and break-downs: metabolism impacts on proteostasis and aging , 2021, Cell death and differentiation.
[37] D. Yee,et al. Disrupting Insulin and IGF Receptor Function in Cancer , 2021, International journal of molecular sciences.
[38] Xiaojie Yuan,et al. Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis , 2020, Nutrition & Diabetes.
[39] F. Flamigni,et al. Nutrients and Pathways that Regulate Health Span and Life Span , 2020, Geriatrics.
[40] Wei Xu,et al. Relationship Between Serum Gamma-Glutamyl Transferase Level and Impaired Fasting Glucose Among Chinese Community-Dwelling Adults: A Follow-Up Observation of 6 Years. , 2020, Metabolic syndrome and related disorders.
[41] R. Kavalar,et al. The value of uPA and PAI-1 levels in triple negative breast cancer , 2020 .
[42] S. Auvin,et al. Ketogenic diet and Neuroinflammation , 2020, Epilepsy Research.
[43] J. DiNicolantonio,et al. Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management , 2020, Open Heart.
[44] R. Holtzer,et al. Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults , 2020, Cells.
[45] A. Foroumadi,et al. A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. , 2020, Bioorganic chemistry.
[46] B. Zhang,et al. Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders , 2019, Therapeutic advances in endocrinology and metabolism.
[47] B. Kofler,et al. Ketogenic diet in the treatment of cancer – Where do we stand? , 2019, Molecular metabolism.
[48] G. Paradies,et al. Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects , 2019, Cells.
[49] S. Uemoto,et al. Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury , 2019, Proceedings of the National Academy of Sciences.
[50] J. Masumoto,et al. The role of interleukin-1 in general pathology , 2019, Inflammation and Regeneration.
[51] L. Piemonti,et al. Low-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes , 2019, Nutrients.
[52] J. Stevens,et al. Prevalence of Optimal Metabolic Health in American Adults: National Health and Nutrition Examination Survey 2009-2016. , 2019, Metabolic syndrome and related disorders.
[53] A. Damjanović,et al. Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy , 2019, BMC Cancer.
[54] J. Holst,et al. Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects. , 2018, Metabolic syndrome and related disorders.
[55] M. Rubin,et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors , 2018, Nature.
[56] A. Bronisz,et al. Pregnancy Ketonemia and Development of the Fetal Central Nervous System , 2018, International journal of endocrinology.
[57] F. Villamena,et al. Nutritional Ketosis and Mitohormesis: Potential Implications for Mitochondrial Function and Human Health , 2018, Journal of nutrition and metabolism.
[58] P. Reynier,et al. How Can a Ketogenic Diet Improve Motor Function? , 2018, Front. Mol. Neurosci..
[59] M. Bache,et al. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume , 2018, Strahlentherapie und Onkologie.
[60] Saran Kumar,et al. Hyperglycemia Impairs Neutrophil Mobilization Leading to Enhanced Metastatic Seeding. , 2017, Cell Reports.
[61] B. Johansson,et al. Gamma-Glutamyltransferase (GGT) as a biomarker of cognitive decline at the end of life: contrasting age and time to death trajectories , 2017, International Psychogeriatrics.
[62] J. DiNicolantonio,et al. Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk , 2017, Open Heart.
[63] A. Itai,et al. Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination , 2017, Oncotarget.
[64] J. B. Jensen,et al. Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients , 2017, Oncotarget.
[65] S. Griffey,et al. A Ketogenic Diet Extends Longevity and Healthspan in Adult Mice. , 2017, Cell metabolism.
[66] E. Verdin,et al. β-Hydroxybutyrate: A Signaling Metabolite. , 2017, Annual review of nutrition.
[67] T. Kohlmann,et al. Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network , 2017, Gynecologic and Obstetric Investigation.
[68] Q. Feng,et al. High glucose levels promote the proliferation of breast cancer cells through GTPases , 2017, Breast cancer.
[69] K. Clarke,et al. Ketone bodies mimic the life span extending properties of caloric restriction , 2017, IUBMB life.
[70] Marcelo González,et al. Pro-angiogenic Role of Insulin: From Physiology to Pathology , 2017, Front. Physiol..
[71] David M. Sabatini,et al. mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.
[72] R. Ortiz,et al. Thyroid Hormone Regulation and Insulin Resistance: Insights From Animals Naturally Adapted to Fasting. , 2017, Physiology.
[73] P. Puchalska,et al. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. , 2017, Cell metabolism.
[74] J. Tan-Shalaby,et al. Ketogenic Diets and Cancer: Emerging Evidence. , 2017, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.
[75] K. Reiss,et al. Regulation of Ketone Body Metabolism and the Role of PPARα , 2016, International journal of molecular sciences.
[76] Xuemei Wu,et al. Oxidative damage induces MCP-1 secretion and macrophage aggregation in age-related macular degeneration (AMD) , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.
[77] M. Duffy,et al. Validated biomarkers: The key to precision treatment in patients with breast cancer. , 2016, Breast.
[78] G. Pacini,et al. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus , 2016, Endocrine reviews.
[79] M. Díaz-Flores,et al. High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells , 2016, Cellular Oncology.
[80] J. Gibbins,et al. Platelet signaling: a complex interplay between inhibitory and activatory networks , 2016, Journal of thrombosis and haemostasis : JTH.
[81] Y. Abed,et al. Obesity and inflammation: the linking mechanism and the complications , 2016, Archives of medical science : AMS.
[82] W. Kraemer,et al. Metabolic characteristics of keto-adapted ultra-endurance runners. , 2016, Metabolism: clinical and experimental.
[83] J. Locasale,et al. The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.
[84] B. Duncan,et al. Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies , 2016, Scientific Reports.
[85] C. Crofts. Hyperinsulinemia: A unifying theory of chronic disease? , 2015 .
[86] P. Urbánek,et al. Redox regulation of FoxO transcription factors , 2015, Redox biology.
[87] Voichita D. Marinescu,et al. Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells , 2015, Oncotarget.
[88] R. Chen,et al. High glucose promotes gastric cancer chemoresistance in vivo and in vitro , 2015, Molecular medicine reports.
[89] T. Seyfried,et al. The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer , 2015, Nutrition & Metabolism.
[90] M. Laville,et al. Insulin Resistance is Associated with MCP1-Mediated Macrophage Accumulation in Skeletal Muscle in Mice and Humans , 2014, PloS one.
[91] A. Brunet,et al. FOXO transcription factors: key regulators of cellular quality control. , 2014, Trends in biochemical sciences.
[92] E. Verdin,et al. Ketone bodies as signaling metabolites , 2014, Trends in Endocrinology & Metabolism.
[93] Mukesh G. Gohel,et al. Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control: An evidence linking oxidative stress, inflammation and glycemic control , 2013, Journal of Diabetes & Metabolic Disorders.
[94] Á. Valverde,et al. Insulin directly stimulates VEGF-A production in the glomerular podocyte. , 2013, American journal of physiology. Renal physiology.
[95] Eric Verdin,et al. Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor , 2013, Science.
[96] T. Kadowaki,et al. Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice , 2012, Diabetologia.
[97] Han Liu,et al. High Glucose Promotes Pancreatic Cancer Cell Proliferation via the Induction of EGF Expression and Transactivation of EGFR , 2011, PloS one.
[98] G. López-Castejón,et al. Understanding the mechanism of IL-1β secretion , 2011, Cytokine & growth factor reviews.
[99] B. Balkau,et al. Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and Women , 2011, Diabetes.
[100] L. Bostad,et al. Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy , 2010, BMC urology.
[101] K. Schmid,et al. Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer , 2010, Cancer.
[102] K. Kinzig,et al. Insulin sensitivity and glucose tolerance are altered by maintenance on a ketogenic diet. , 2010, Endocrinology.
[103] B. Draznin,et al. Mitogenic action of insulin: friend, foe or ‘frenemy’? , 2010, Diabetologia.
[104] J. Zavadil,et al. Insulin acts through FOXO3a to activate transcription of plasminogen activator inhibitor type 1. , 2009, Molecular endocrinology.
[105] H. Tissenbaum,et al. Converging Pathways in Lifespan Regulation , 2009, Current Biology.
[106] S. Amini,et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[107] M. Pollak,et al. Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.
[108] R. Balsara,et al. Plasminogen activator inhibitor-1: The double-edged sword in apoptosis , 2008, Thrombosis and Haemostasis.
[109] Katsuhiko Yano,et al. FOXO3A genotype is strongly associated with human longevity , 2008, Proceedings of the National Academy of Sciences.
[110] Z. Tulassay,et al. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer , 2008, BMC Cancer.
[111] A. Hamsten,et al. Insulin regulation of MCP-1 in human adipose tissue of obese and lean women. , 2008, American journal of physiology. Endocrinology and metabolism.
[112] M. Juárez-Oropeza,et al. The Respiratory Exchange Ratio is Associated with Fitness Indicators Both in Trained and Untrained Men: A Possible Application for People with Reduced Exercise Tolerance , 2008, Clinical medicine. Circulatory, respiratory and pulmonary medicine.
[113] A. Puisieux,et al. Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer , 2006, BMC Cancer.
[114] D. Loskutoff,et al. Molecular mechanisms of tumor necrosis factor‐α‐mediated plasminogen activator inhibitor‐1 expression in adipocytes , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[115] R. Mayeux,et al. Hyperinsulinemia and risk of Alzheimer disease , 2004, Neurology.
[116] M. Kiechle,et al. Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer , 2004, Thrombosis and Haemostasis.
[117] Claudio Franceschi,et al. Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. , 2003, American journal of physiology. Endocrinology and metabolism.
[118] P. Morange,et al. Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk , 2003, Journal of thrombosis and haemostasis : JTH.
[119] D. Loskutoff,et al. Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[120] Martin Holzenberger,et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.
[121] D. Haro,et al. Down-regulation of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by insulin: the role of the forkhead transcription factor FKHRL1. , 2002, The Biochemical journal.
[122] D. Dunger,et al. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. , 2002, Journal of the National Cancer Institute.
[123] L. Devy,et al. The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[124] D. Loskutoff,et al. Insulin Continues to Induce Plasminogen Activator Inhibitor 1 Gene Expression in Insulin-Resistant Mice and Adipocytes , 2000, Molecular medicine.
[125] E. Van Obberghen,et al. Insulin and Insulin-like Growth Factor-I Induce Vascular Endothelial Growth Factor mRNA Expression via Different Signaling Pathways* , 2000, The Journal of Biological Chemistry.
[126] D. Accili,et al. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. , 2000, Endocrinology.
[127] G. Brooks,et al. Respiratory gas-exchange ratios during graded exercise in fed and fasted trained and untrained men. , 1999, Journal of applied physiology.
[128] G. Siest,et al. gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. , 1998, Free radical biology & medicine.
[129] D. Accili,et al. Effect of Insulin on Farnesyltransferase , 1998, The Journal of Biological Chemistry.
[130] M. Skobe,et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization , 1998, Nature Medicine.
[131] C. Martínez-A,et al. The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness , 1998, The Journal of experimental medicine.
[132] M. Goalstone,et al. What does insulin do to Ras? , 1998, Cellular signalling.
[133] M. Goalstone,et al. Hyperinsulinemia potentiates activation of p21Ras by growth factors. , 1997, Endocrinology.
[134] P. Morange,et al. Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease , 1997, Diabetes.
[135] C. Delgado,et al. Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[136] B. Bennett,et al. Plasminogen activator inhibitor (PAI‐1) in plasma and platelets , 1988, British journal of haematology.
[137] D. Hill,et al. Insulin as a Growth Factor , 1985, Pediatric Research.
[138] E. Ravussin,et al. Respiratory quotients lower than 0.70 in ketogenic diets. , 1980, The American journal of clinical nutrition.
[139] L. Hayflick,et al. The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.
[140] N. El-Badri,et al. Pericytes: The Role of Multipotent Stem Cells in Vascular Maintenance and Regenerative Medicine. , 2018, Advances in experimental medicine and biology.
[141] Victoria S. Sprung,et al. A pilot study to explore the role of a low-carbohydrate intervention to improve GGT levels and HbA 1 c , 2015 .
[142] S Kumanyika,et al. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist–Hip Ratio , 2010, European Journal of Clinical Nutrition.
[143] Y. Iwadate,et al. High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas. , 2008, Anticancer research.
[144] S. Grundy. Gamma-glutamyl transferase: another biomarker for metabolic syndrome and cardiovascular risk. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[145] J. Seidell,et al. The public health impact of obesity. , 2001, Annual review of public health.